TipRanks
Go Ultimate55% OFF

James Frates Insider Profile

11 Followers

James Frates, CFO at Amylyx Pharmaceuticals Inc, holds 410.97K shares in Amylyx Pharmaceuticals Inc (Ticker: AMLX), holds 0.00 shares in SAGE Therapeutics (Ticker: SAGE), holds 247.50K shares in Alkermes (Ticker: ALKS).

James Frates's Trading History

AMLX
Amylyx Pharmaceuticals Inc
Aug 20, 2026CFOUninformative Buy―$11.86M
SAGE
SAGE Therapeutics
Jul 31, 2025―Uninformative Sell―$0.00
ALKS
Alkermes
May 14, 2020SVP, Alks Inc; CFO ALKSUninformative Buy258.08K$11.22M

You May Also Like

James Frates insider profile FAQ

What is the percentage of profitable transactions made by James Frates?
The percentage of profitable transactions made by James Frates is 40%.
What is the average return per transaction made by James Frates?
The average return per transaction made by James Frates is -40.10%.
What stocks does James Frates hold?
James Frates holds: AMLX, ALKS, SAGE stocks.
What was James Frates's most profitable transaction?
James Frates’s most profitable transaction was an Informative Buy of SAGE stock on July 23, 2014. The return on the trade was 173.30%.
What is James Frates's role in Amylyx Pharmaceuticals Inc?
James Frates's role in Amylyx Pharmaceuticals Inc is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.